Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

- PMLiVE

Takeda’s enzyme replacement therapy approved by FDA for rare blood clotting disorder

The ultra-rare inherited disease is estimated to affect fewer than 1,000 people in the US

- PMLiVE

GSK’s momelotinib recommended by CHMP to treat myelofibrosis patients with anaemia

About 40% of patients have moderate-to-severe anaemia at the time of diagnosis

- PMLiVE

Redefining medical communications in the age of omnichannel engagement

By Chris Hall

- PMLiVE

Takeda’s Fruzaqla receives FDA approval for metastatic colorectal cancer

More than 150,000 new cases of colorectal cancer will be diagnosed in the US in 2023

- PMLiVE

Valneva’s chikungunya vaccine approved by FDA for adults at increased exposure risk

The decision makes Ixchiq, which is administered as a single injection, the world's first licensed vaccine against the mosquito-borne disease

- PMLiVE

New £5m project launched to bring Alzheimer’s blood tests to the NHS

Blood tests for the condition could become available on the NHS within five years

- PMLiVE

NICE recommends Chiesi’s alpha-mannosidosis enzyme replacement therapy

Alpha-mannosidosis, an extremely rare inherited condition characterised by a broad range of impairments, affects approximately 25 people in England

- PMLiVE

UK antibiotic subscription model found by OHE as key to supporting investment

The OHE report offers valuable insights into investor views of the subscription model

- PMLiVE

Vaccitech renames as Barinthus Biotherapeutics to focus on immunotherapy

The clinical-stage biopharma said the new name represents the expansion of its efforts beyond vaccines

- PMLiVE

Focusing in on real-world evidence and its capabilities

The surge in real-world data presents opportunities for greater understanding of patients and conditions, but it needs standardising and harmonising to liberate its full potential

- PMLiVE

PM Society announces new chair for 2024

Dom Marchant, chief creative officer at OPEN Health, has been part of the PM Society executive team for seven years

- PMLiVE

Changing What’s Possible for Women in Healthcare

Career choices are driven by many factors. In medicine, doctors are often drawn to a particular specialty following a personal experience.That’s the case with both of the renowned speakers in...

Medscape Education

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links